Zimmer Biomet
ProfileJobs

Zimmer Biomet

Suggest Edit
    • HealthManufacturing & Industrialmedical devicesmedtech

    Zimmer Biomet is a musculoskeletal healthcare company. The Company designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office based technologies; spine, craniomaxillofacial and thoracic products; dental implants; and related surgical products. Zimmer Biomet's products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues.

    Revenue(FY, 2016)
    $7.7 B
    Market capitalization(2017-10-31)
    $24.6 B
    Type
    Public
    HQ
    Warsaw, US
    Founded
    1927
    Size (employees)
    18,500 (est)
    Website
    zimmerbiomet.com
    Zimmer Biomet was founded in 1927 and is headquartered in Warsaw, US
    Report incorrect company information

    Key People/Management at Zimmer Biomet

    Bryan Hanson

    Bryan Hanson

    President and Chief Executive Officer
    Derek Davis

    Derek Davis

    Interim Vice President, Investor Relations and Vice President, Global Integration
    Robert Delp

    Robert Delp

    President, Americas
    William Fisher

    William Fisher

    Senior Vice President, Global Human Resources
    Daniel Florin

    Daniel Florin

    Senior Vice President and Chief Financial Officer
    Adrian Furey

    Adrian Furey

    Senior Vice President, Global Operations and Logistics
    Show more

    Zimmer Biomet Office Locations

    Zimmer Biomet has an office in Warsaw
    Warsaw, US (HQ)
    345 E Main St
    Warsaw, US
    1800 W Center St
    Show all (2)
    Report incorrect company information

    Zimmer Biomet Financials and Metrics

    Zimmer Biomet Financials

    Zimmer Biomet's revenue was reported to be $7.68 b in FY, 2016 which is a 28.1% increase from the previous period.
    USD

    Revenue (Q3, 2017)

    		1.8 b

    Net income (Q3, 2017)

    		98.8 m

    EBIT (Q3, 2017)

    		213.4 m

    Market capitalization (31-Oct-2017)

    		24.6 b

    Closing share price (31-Oct-2017)

    		121.4
    Zimmer Biomet's current market capitalization is $24.6 b.
    Annual
    USDFY, 2013FY, 2014FY, 2015FY, 2016

    Revenue

    		4.6 b4.7 b6 b7.7 b

    Revenue growth, %

    		1%28%28%

    Cost of goods sold

    		1.3 b1.2 b1.8 b2.4 b

    Gross profit

    		3.3 b3.4 b4.2 b5.3 b
    Quarterly
    USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

    Revenue

    		1.1 b1.2 b1.2 b1.1 b1.1 b1.2 b176.2 m1.9 b1.9 b1.8 b2 b2 b1.8 b

    Cost of goods sold

    		328.8 m305.4 m333.2 m298.3 m278.7 m290.5 m552.1 m635.2 m640.1 m479.3 m512.9 m527.7 m

    Gross profit

    		745.5 m856.1 m849.7 m807.7 m855.7 m877.1 m(375.9 m)1.3 b1.3 b1.4 b1.5 b1.4 b

    Gross profit Margin, %

    		69%74%72%73%75%75%(213%)67%67%74%74%73%
    show all
    Annual
    USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

    Cash

    		1.1 b1.1 b1.5 b634.1 m

    Accounts Receivable

    		936.6 m912.1 m1.4 b1.6 b

    Prepaid Expenses

    		107.1 m193.7 m538.4 m465.7 m

    Inventories

    		1.1 b1.2 b2.3 b2 b
    Quarterly
    USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

    Cash

    		917.4 m882.7 m968.7 m967.3 m8.8 b1.4 b1.5 b996.8 m976.3 m475.3 m1 b450 m480.8 m

    Accounts Receivable

    		869.8 m1.5 b1.4 b1.6 b1.6 b1.6 b1.6 b1.4 b

    Prepaid Expenses

    		246.8 m551.7 m475.8 m420.7 m518.9 m535.8 m463.3 m527.2 m

    Inventories

    		1.1 b1.1 b1.1 b1.2 b1.2 b2.4 b2.4 b2.1 b2 b2.1 b2 b2 b2.1 b
    show all
    Annual
    USDFY, 2013FY, 2014FY, 2015FY, 2016

    Net Income

    		759.2 m719 m146.2 m304.6 m

    Depreciation and Amortization

    		358.5 m375.8 m712.4 m1 b

    Inventories

    		(128.4 m)(154.1 m)(205.4 m)76.4 m

    Accounts Payable

    		38.3 m120.1 m(263.1 m)28.7 m
    Quarterly
    USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

    Net Income

    		154.1 m221.1 m176.1 m165.3 m176.8 m18.6 m19.5 m105.8 m77 m234.9 m299.3 m483.4 m98.8 m

    Depreciation and Amortization

    		89 m188.6 m428.1 m246.9 m499.2 m787.3 m267.6 m531.7 m

    Inventories

    		(62.2 m)(149.9 m)(196.5 m)38.3 m60.2 m44.2 m(11.5 m)(68.8 m)2.1 b

    Accounts Payable

    		(149.5 m)95.8 m(251.5 m)(120.7 m)(141.9 m)(76 m)(137 m)(203.7 m)327.1 m
    show all
    USDY, 2017

    Revenue/Employee

    		98.3 k
    Show all financial metrics

    Zimmer Biomet Operating Metrics

    FY, 2014FY, 2015FY, 2016

    Countries

    		100 100 100

    Patents and Patent Applications

    		4.50 k7 k8 k
    Show all operating metrics

    Zimmer Biomet Acquisitions / Subsidiaries

    Acquired CompanyDateDeal Size
    Accelero Health Partners
    Biomet
    Biomet 3i
    Biomet Biologics
    Biomet CV Holdings
    Biomet Europe Holdings
    Biomet Europe Ltd.
    Biomet Fair Lawn LLC
    Biomet Finance US
    Biomet Holdings US Inc.
    Show more
    Report incorrect company information

    Competitors

    Medtronic
    Health - Public
    Stryker
    Health - Public
    Edwards Lifesciences
    Health - Public
    Varian Medical Systems
    Health - Public
    Wright Medical
    Health - Public
    Orthofix
    Health - Public
    Compare competitors

    Zimmer Biomet News and Updates

    January 17, 2018

    Global Orthopedic Splints Market 2017: Key Players – DJO, DeRoyal, Zimmer Biomet, ORFIT, Mika Medical

    WiseGuyReports.com adds “Orthopedic Splints Market 2017 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2023” Posted via Industry Today. Follow us on Twitter @IndustryToday
    Report incorrect company information
    Download PDF